Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.

@article{MaloneLee2001TolterodineST,
  title={Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.},
  author={James Malone-Lee and B Shaffu and Curuchi Anand and Christine Powell},
  journal={The Journal of urology},
  year={2001},
  volume={165 5},
  pages={
          1452-6
        }
}
PURPOSE We compared the tolerability and clinical efficacy of tolterodine with those of oxybutynin in patients with an overactive bladder using an upward oxybutynin dose titration strategy analogous to that used in routine clinical practice in the United Kingdom and Republic of Ireland. MATERIALS AND METHODS In a randomized double-blind trial 378 male and female patients 50 years old or older with symptoms of overactive bladder (a urinary frequency of 8 or more voids per 24 hours with urgency… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 52 CITATIONS, ESTIMATED 50% COVERAGE

Veränderungen der Muskarinrezeptoren der alternden Harnblase

  • Der Urologe, Ausgabe A
  • 2004
VIEW 13 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Overactive bladder - 18 years - Part II.

  • International braz j urol : official journal of the Brazilian Society of Urology
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2001
2017

CITATION STATISTICS

  • 4 Highly Influenced Citations